NCT02705846View on ClinicalTrials.gov

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

RecruitingOBSERVATIONAL
Enrollment

4,260

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2035

Conditions
Prostate Cancer
Interventions
OTHER

Observation of treatment outcomes via Questionnaire

Collection of treatment data from participants

Trial Locations (1)

SM2 5PT

RECRUITING

Institute of Cancer Research and Royal Marsden Hospital, Sutton

All Listed Sponsors
lead

Institute of Cancer Research, United Kingdom

OTHER